Best Shopping Centers in Brazil

© 2012 BlogName - All rights reserved.

Firstyme WordPress Theme.
Designed by Charlie Asemota.

Clay Siegall’s Passion And Leadership Is The Equation Creating Seattle Genetics’ Success

February 28, 2017 - Author: steph - No Comments


With many companies now in the business of the cancer field, it can be hard to differentiate between them. Seattle Genetics however is one of the more interesting of these companies, focused on creating innovative technology to advance cancer therapies. Their success can easily be seen in the tripling of their stock price in the last 5 years.

Behind the helm is CEO, Clay Siegall. Since the beginning of his career, Dr. Siegall has had a deep passion for improving the lives of cancer patients. He founded Seattle Genetics in 1998, working tirelessly ever since then to create amazing advancements in cancer research and innovative therapies for those patients.

After receiving his Ph.D. from George Washington University, Dr. Siegall has become an accomplished scientist. He has worked as a Senior Research Investigator and Principal Scientist at Bristol-Myers Squibb Pharmaceutical Research Institute and a Staff Fellow at the National Cancer Institute. It was after these positions that he moved on to create Seattle Genetics.

Clay Siegall has been committed to important cancer research. His true desire to help patients has guided him to become one of the foremost leaders in the cancer research field. Seattle Genetics has reached new levels of research advancements, developing the first antibody-drug conjugates (ADCs) that have received FDA approval. ADCETRIS was their first ADC, now expanding its impact all over the world to over 60 countries. Dr. Siegall’s passion and perseverance is evident by his assurance of FDA approval for ADCETRIS and his steadfast commitment to ensuring the drug is available to as many patients around the world as possible.

Aside from being a brilliant scientist and passionate member of society, Clay Siegall is also known for his leadership in fundraising abilities. He has personally secured over $1.2 billion in both private and public funding for Seattle Genetics for its endeavors. His perfect blend of scientific know-how and leadership skills have attributed to Seattle Genetics’ brilliant success.

Dr. Siegall has received many awards for his leadership and scientific abilities. In 2012, he was named the Pacific Northwest Ernst &Young Entrepreneur of the Year. In 2013, he became the University of Maryland’s Alumnus of the Year for Computer, Math and Natural Sciences.

Categories: Genetics

Leave a Reply